Primary leiomyosarcoma of the gastrointestinal tract is a rare but highly aggressive neoplasm. The incidence of colonic leiomyosarcoma is approximately 0.45 cases per million population and it constitutes 0.12% of all colorectal malignancies. 1 This rare malignancy possesses aggressive nature and mimicry to other relatively benign gastrointestinal diseases including gastrointestinal stromal tumour (GIST). 1 Leiomyosarcoma occurs mainly in the fifth and sixth decade of life. Abdominal mass and pain are the most common presentations followed by gastrointestinal bleeding and abdominal distension. Luminal occlusion and perforation of the bowel wall are uncommon. 2 Leiomyosarcoma poses a substantial preoperative diagnostic challenge to clinicians especially during emergency circumstances because there are no established diagnostic imaging criteria for leiomyosarcoma. Leiomyosarcoma presents with non-specific features on computed tomography scan. It appears non-homogeneous, irregular, and lobular-shaped with a size usually >5 cm, and it is associated with central necrotic areas and connection to the intestinal lumen. 3 Unfortunately, histological analysis of superficial biopsy specimens has significant sampling error and leiomyosarcoma can be misdiagnosed as benign leiomyoma. The preoperative histological diagnosis of leiomyosarcoma is adequate in only 29% of rectal leiomyosarcoma cases in some studies. 4 Moreover, preoperative biopsy carries a theoretical risk for tumour capsule rupture and peritoneal seeding.
The differential diagnoses for leiomyosarcoma include submucosal tumours such as adenocarcinoma, lymphoma, and GIST. Adenocarcinoma and lymphoma can be readily differentiated from leiomyosarcoma on microscopic examination, yet GISTs and leiomyosarcomas carry a lot of resemblance in both gross and histological appearance.
Immunohistochemically, approximately 94% of GISTs carry c-kit mutations while 95% are positive for CD117. The c-kit mutation-negative GIST is usually associated with platelet-derived growth factor receptor alpha (PDGFRA) mutations. 5 In contrast, leiomyosarcoma shows features of smooth muscle differentiation with cellular atypia, abundant mitoses and areas of necrosis, reflecting their aggressive nature. Leiomyosarcoma is actin and desmin reactive but CD117, CD34 and DOG1.1 are typically absent. There is also lack of mutation of c-kit and PDGFRA genes in leiomyosarcoma. [6] [7] [8] [9] [10] [11] We recently encountered an exemplar case of leiomyosarcoma. A 68-year-old Chinese man presented to our hospital with progressively decreased bowel opening and abdominal distension for a few weeks. There was no abdominal pain or vomiting. He was a chronic smoker and his past health was unremarkable. His vital signs were stable and he remained afebrile during hospital stay. On physical examination, his abdomen was distended but without tenderness nor peritoneal signs. His blood test results showed leucocytosis (white blood cell count 10 × 10 9 /L). Abdominal plain X-ray showed a grossly dilated large bowel with cut-off at the descending colon, but the small bowel was not dilated. Subsequent computed tomography scan of the abdomen and pelvis with contrast revealed a 3.2-cm × 2.7-cm × 5.1-cm obstructive mass at the lower descending colon compatible with carcinoma of the colon with an ill-defined plane between the adjacent peritoneum and the left iliacus muscle ( Fig  1) . Emergency Hartmann operation and en bloc resection of retroperitoneal encroaching tumour bulk involving the iliacus muscle down to the iliac crest bone were performed. Intra-operative findings included a 4-cm distal descending colonic tumour with complete obstruction and invasion to the peritoneal side wall down to the iliacus muscle and iliac crest, as well as an oedematous, grossly dilated, and faecal-loaded large bowel with competent ileocecal valve causing closed loop obstruction. Pathology report of the resected specimen revealed moderately cellular spindle cell tumour involving the muscularis propria and the extramural tissue of the colonic wall, sparing the overlying mucosa and submucosa. The tumour was composed of interlacing fascicles of spindle cells with some epithelioid appearance (Fig 2) . Mitotic index was up to four mitotic figures per 10 high power fields.
COMMENTARY
Immunohistochemically, the specimen was diffusely positive for desmin and actin (smooth muscle actin) and negative for MNF116, S-100, CD34, DOG-1, and c-kit mutations. The overall features were those of leiomyosarcoma. Follow-up positron emission tomography-computed tomography scan did not show any metastasis or residual tumour. Multidisciplinary consensus was reached with oncologists concluding no adjuvant chemotherapy was required. The patient had no functional deficits despite partial excision of the iliacus. The patient has attended regular follow-up examinations in our unit without recurrence.
Complete excision with negative margin (R0 resection) offers the best chance of cure for gastrointestinal leiomyosarcoma, and there is limited evidence supporting the use of radiotherapy and chemotherapy. En bloc excision of involved adjacent organs is necessary to achieve cure in locally advanced leiomyosarcoma. Histological grade, tumour size and location are prognostic factors, determining the likelihood of distant metastases and disease specific survival. 12 In a large retrospective study, the 5-year disease-specific survival was 38.9% with a median survival of 34.1 months. Approximately 50% patients will eventually have local recurrence and distant metastases despite adequate local control of their disease. 13 Continued surveillance in these patients beyond 5 years is necessary and should include imaging of the lungs along with abdomen and pelvis given hepatic and pulmonary metastases constitutes 20% and 30% of all first-site of recurrence, respectively. 14 Gastrointestinal leiomyosarcoma seldom presents as intestinal obstruction and invasion to adjacent muscle as in our patient. The indistinct features of leiomyosarcoma on different imaging modalities pose substantial preoperative diagnostic challenge to clinicians. Although there is no strong evidence for the role of adjuvant therapies, curative treatment is possible with a margin-clear en bloc excision and close surveillance with imaging.
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